nodes	percent_of_prediction	percent_of_DWPC	metapath
Atomoxetine—HTR1D—meninx—Behcet's disease	0.224	0.229	CbGeAlD
Atomoxetine—HTR2A—pulmonary artery—Behcet's disease	0.0438	0.0447	CbGeAlD
Atomoxetine—HTR2A—vein—Behcet's disease	0.0398	0.0406	CbGeAlD
Atomoxetine—HTR1B—artery—Behcet's disease	0.0337	0.0344	CbGeAlD
Atomoxetine—HTR1D—artery—Behcet's disease	0.0327	0.0333	CbGeAlD
Atomoxetine—HTR2A—pons—Behcet's disease	0.031	0.0317	CbGeAlD
Atomoxetine—HTR1B—blood vessel—Behcet's disease	0.0263	0.0268	CbGeAlD
Atomoxetine—NPY1R—mammalian vulva—Behcet's disease	0.0262	0.0267	CbGeAlD
Atomoxetine—HTR1D—blood vessel—Behcet's disease	0.0254	0.026	CbGeAlD
Atomoxetine—NPY1R—nervous system—Behcet's disease	0.0177	0.0181	CbGeAlD
Atomoxetine—NPY1R—central nervous system—Behcet's disease	0.0171	0.0174	CbGeAlD
Atomoxetine—HTR2A—artery—Behcet's disease	0.0162	0.0166	CbGeAlD
Atomoxetine—HTR1B—brainstem—Behcet's disease	0.0144	0.0147	CbGeAlD
Atomoxetine—SLC6A3—brainstem—Behcet's disease	0.0142	0.0145	CbGeAlD
Atomoxetine—HTR1D—brainstem—Behcet's disease	0.0139	0.0142	CbGeAlD
Atomoxetine—HTR2C—brainstem—Behcet's disease	0.0138	0.0141	CbGeAlD
Atomoxetine—HTR2A—endothelium—Behcet's disease	0.0137	0.014	CbGeAlD
Atomoxetine—NPY1R—brain—Behcet's disease	0.0136	0.0138	CbGeAlD
Atomoxetine—HTR1D—eye—Behcet's disease	0.0135	0.0138	CbGeAlD
Atomoxetine—SLC6A4—brainstem—Behcet's disease	0.0131	0.0133	CbGeAlD
Atomoxetine—HTR2A—blood vessel—Behcet's disease	0.0126	0.0129	CbGeAlD
Atomoxetine—HTR6—nervous system—Behcet's disease	0.0125	0.0127	CbGeAlD
Atomoxetine—HTR6—central nervous system—Behcet's disease	0.012	0.0123	CbGeAlD
Atomoxetine—SLC6A2—brainstem—Behcet's disease	0.0115	0.0117	CbGeAlD
Atomoxetine—Ketoprofen—CXCL8—Behcet's disease	0.0114	0.569	CrCbGaD
Atomoxetine—HTR2C—medulla oblongata—Behcet's disease	0.0096	0.0098	CbGeAlD
Atomoxetine—HTR6—brain—Behcet's disease	0.00954	0.00974	CbGeAlD
Atomoxetine—HTR1B—midbrain—Behcet's disease	0.00916	0.00934	CbGeAlD
Atomoxetine—SLC6A3—midbrain—Behcet's disease	0.00908	0.00927	CbGeAlD
Atomoxetine—HTR1B—spinal cord—Behcet's disease	0.00893	0.00912	CbGeAlD
Atomoxetine—HTR1D—midbrain—Behcet's disease	0.00886	0.00905	CbGeAlD
Atomoxetine—SLC6A3—spinal cord—Behcet's disease	0.00886	0.00904	CbGeAlD
Atomoxetine—HTR2C—midbrain—Behcet's disease	0.00878	0.00896	CbGeAlD
Atomoxetine—Pseudoephedrine—TNF—Behcet's disease	0.00864	0.431	CrCbGaD
Atomoxetine—HTR2C—spinal cord—Behcet's disease	0.00856	0.00874	CbGeAlD
Atomoxetine—SLC6A4—midbrain—Behcet's disease	0.00832	0.00849	CbGeAlD
Atomoxetine—SLC6A4—spinal cord—Behcet's disease	0.00812	0.00828	CbGeAlD
Atomoxetine—SLC6A2—medulla oblongata—Behcet's disease	0.00802	0.00818	CbGeAlD
Atomoxetine—HTR1B—nervous system—Behcet's disease	0.00753	0.00768	CbGeAlD
Atomoxetine—SLC6A3—nervous system—Behcet's disease	0.00747	0.00762	CbGeAlD
Atomoxetine—HTR1D—nervous system—Behcet's disease	0.00729	0.00744	CbGeAlD
Atomoxetine—HTR1B—central nervous system—Behcet's disease	0.00725	0.00739	CbGeAlD
Atomoxetine—HTR2C—nervous system—Behcet's disease	0.00722	0.00736	CbGeAlD
Atomoxetine—SLC6A3—central nervous system—Behcet's disease	0.00719	0.00733	CbGeAlD
Atomoxetine—HTR1D—central nervous system—Behcet's disease	0.00702	0.00716	CbGeAlD
Atomoxetine—HTR2C—central nervous system—Behcet's disease	0.00695	0.00709	CbGeAlD
Atomoxetine—HTR2A—brainstem—Behcet's disease	0.00691	0.00705	CbGeAlD
Atomoxetine—SLC6A4—nervous system—Behcet's disease	0.00684	0.00698	CbGeAlD
Atomoxetine—HTR2A—eye—Behcet's disease	0.00673	0.00686	CbGeAlD
Atomoxetine—HTR2A—retina—Behcet's disease	0.00667	0.0068	CbGeAlD
Atomoxetine—SLC6A4—central nervous system—Behcet's disease	0.00659	0.00672	CbGeAlD
Atomoxetine—CYP2D6—brainstem—Behcet's disease	0.00629	0.00642	CbGeAlD
Atomoxetine—SLC6A2—nervous system—Behcet's disease	0.00602	0.00615	CbGeAlD
Atomoxetine—SLC6A2—central nervous system—Behcet's disease	0.0058	0.00592	CbGeAlD
Atomoxetine—HTR1B—brain—Behcet's disease	0.00575	0.00587	CbGeAlD
Atomoxetine—SLC6A3—brain—Behcet's disease	0.00571	0.00582	CbGeAlD
Atomoxetine—HTR1D—brain—Behcet's disease	0.00557	0.00568	CbGeAlD
Atomoxetine—HTR2C—brain—Behcet's disease	0.00552	0.00563	CbGeAlD
Atomoxetine—SLC6A4—brain—Behcet's disease	0.00523	0.00534	CbGeAlD
Atomoxetine—HTR2A—medulla oblongata—Behcet's disease	0.00482	0.00492	CbGeAlD
Atomoxetine—SLC6A2—brain—Behcet's disease	0.0046	0.0047	CbGeAlD
Atomoxetine—HTR2A—midbrain—Behcet's disease	0.0044	0.00449	CbGeAlD
Atomoxetine—HTR2A—spinal cord—Behcet's disease	0.0043	0.00438	CbGeAlD
Atomoxetine—HTR2A—nervous system—Behcet's disease	0.00362	0.00369	CbGeAlD
Atomoxetine—HTR2A—central nervous system—Behcet's disease	0.00349	0.00356	CbGeAlD
Atomoxetine—CYP3A4—nervous system—Behcet's disease	0.00335	0.00342	CbGeAlD
Atomoxetine—CYP2D6—nervous system—Behcet's disease	0.0033	0.00337	CbGeAlD
Atomoxetine—CYP3A4—central nervous system—Behcet's disease	0.00323	0.00329	CbGeAlD
Atomoxetine—CYP2D6—central nervous system—Behcet's disease	0.00317	0.00324	CbGeAlD
Atomoxetine—HTR2A—brain—Behcet's disease	0.00277	0.00282	CbGeAlD
Atomoxetine—CYP2D6—brain—Behcet's disease	0.00252	0.00257	CbGeAlD
